Instead of placebo (empty vaccine) in the first domestic vaccine, which started human trials in Turkey, Sinovac vaccine will be used.
Covid-19 domestic vaccine developed by the Vaccine Research and Development Center (ERAGEM) and Good Clinical Practice and Research Center (İKUM) within the body of Kayseri Erciyes University (ERÜ) and supported by the Ministry of Health and the Turkish Health Institutes (TÜSEB). Phase-1 study was conducted on 44 volunteers.
‘END OF MONTH’ SIGN TO PHASE 3 STUDY
The Phase-2 study of the inactive vaccine, which started in February, was completed on April 9. In the reporting of Phase-2, which was conducted on 250 volunteers, the final stage was reached. Phase-3 study of the domestic vaccine is planned to begin at the end of this month.
SINOVAC WILL BE USED
In the Phase-3 phase of the domestic vaccine, some of the volunteers will use China’s Sinovac vaccine, which is widely used in Turkey, instead of a placebo.
Some of the people in the similar group who will volunteer in the study will be given the local vaccine and the Sinovac vaccine will be applied to some.
Thus, in addition to the effectiveness of the domestic vaccine, its protection against the inactive Sinovac vaccine will be compared. At the same time, everyone who volunteers in the Phase-3 phase will be vaccinated.